MetLife (MET)
(Delayed Data from NYSE)
$78.43 USD
+0.01 (0.01%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $78.42 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$78.43 USD
+0.01 (0.01%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $78.42 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth F Momentum C VGM
Zacks News
MetLife (MET) Ventures Into Single Family Rental Space in the US
by Zacks Equity Research
MetLife's (MET) asset management arm, MetLife Investment Management, ventures into single-family rental space with a new fund, securing capital commitments of $390 million.
Why MetLife (MET) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
Top Research Reports for Verizon, ICICI Bank & MercadoLibre
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Verizon Communications Inc. (VZ), ICICI Bank Limited (IBN) and MercadoLibre, Inc. (MELI).
MetLife (MET) Q2 Earnings Beat on Higher Investment Returns
by Zacks Equity Research
MetLife (MET) exits the second quarter with cash and cash equivalents of $15,417 million.
MetLife (MET) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for MetLife (MET) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
MetLife (MET) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of 4.86% and 8.80%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Enact Holdings, Inc. (ACT) Q2 Earnings Beat Estimates
by Zacks Equity Research
Enact Holdings, Inc. (ACT) delivered earnings and revenue surprises of 34.15% and 2.81%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stocks to Post Q2 Earnings on Aug 2: LNC, MET & More
by Sushmita Sarker
Prudent rate hikes, stronger mortgage market and higher reinvestment rate, partly offset by significant catastrophe losses, are likely to have influenced the second-quarter performances of LNC, MET, AFG, RDN and MTG.
Will Reduced Premiums Hurt MetLife's (MET) Q2 Earnings?
by Zacks Equity Research
MetLife's (MET) second-quarter results are likely to reflect lower profits in the Retirement & Income Solutions and MetLife Holdings businesses.
Everest Group (EG) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Everest Group (EG) delivered earnings and revenue surprises of 37.03% and 0.88%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: MetLife (MET) Q2 Earnings Expected to Decline
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Lemonade (LMND) Soars 15.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Lemonade (LMND) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks Industry Outlook Highlights MetLife, American International Group, Prudential, Assurant and Corebridge Financial
by Zacks Equity Research
MetLife, American International Group, Prudential, Assurant and Corebridge Financial have been highlighted in this Industry Outlook article.
5 Stocks to Watch From the Soft Multiline Insurance Industry
by Tanuka De
Better pricing, product redesigns, technological advancement, high inflation and rate rise are expected to aid multiline insurers like MET, AIG, PRU, AIZ and CRBG.
Why MetLife (MET) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
MET or AIG: Which Multiline Insurance Stock is Better-Positioned?
by Zacks Equity Research
MetLife (MET) and American International (AIG) are well-positioned to expand in the multiline insurance space. Let's find out which one fares better via comparative evaluation.
MetLife (MET) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
MetLife (MET) Expands Partnership With DentalInsurance.com
by Zacks Equity Research
MetLife (MET) collaborates with DentalInsurance.com to provide impeccable service to customers purchasing dental health insurance.
MetLife (MET) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
MetLife (MET) closed the most recent trading day at $54.98, moving +1.7% from the previous trading session.
MetLife (MET) Gains As Market Dips: What You Should Know
by Zacks Equity Research
MetLife (MET) closed the most recent trading day at $55.50, moving +0.62% from the previous trading session.
MetLife (MET) and Lyra Unite to Improve Employee Mental Health
by Zacks Equity Research
MetLife (MET) partners with Lyra to provide employees with mental health solutions and improve their well-being in difficult situations.
MetLife (MET) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
Zacks Investment Ideas feature highlights: Assurant, Radian Group, Old Republic International , MetLife and Prudential Financial
by Zacks Equity Research
Assurant, Radian Group, Old Republic International , MetLife and Prudential Financial are part of the Zacks Investment Ideas article.
5 Dividend-Paying Multiline Insurers That Ensure Stable Income
by Tanuka De
Multiline insurers like Assurant Inc. (AIZ), Radian Group Inc. (RDN), Old Republic International Corporation (ORI), MetLife Inc. (MET) and Prudential Financial Inc. (PRU), which have an impressive dividend history, offer a breather amid volatility.
MetLife (MET) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, MetLife (MET) closed at $53.76, marking a -1.99% move from the previous day.